[Current status of drug treatment of endometrial carcinoma].
D000616:Aminoglutethimide / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D010166:Palliative Care; D010347:Patient Care Planning; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000628:therapy
D000970:Antineoplastic Agents; D004965:Estrogen Antagonists; D000616:Aminoglutethimide; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone
Gegenwärtiger Stand der medikamentösen Behandlung des Endometriumkarzinoms.